Skip to main content
Log in

Plasma concentration and vascular effect of β-endorphin in spontaneously hypertensive and Wistar Kyoto rats

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

In order to find out whether β-endorphin (β-E) is involved in the development of hypertension, we performed two series of experiments. Firstly, spontaneously hypertensive rats (SHR) and their normotensive Wistar Kyoto controls (WKY) were submitted to ether stress. Plasma concentrations of β-endorphin-like immunoreactivity (β-EI), adrenocorticotropin (ACTH) and α-melanotropin (α-MSH) were measured by radioimmunoassay. The basal concentration of β-EI was similar in WKY and SHR, whereas WKY had higher levels of ACTH and lower levels of α-MSH than SHR. In both strains acute stress enhanced the plasma concentration of β-EI to the same extent and with a similar time-course. The increase of plasma α-El coincided with a rise in ACTH but not α-MSH. Gel chromatography of β-EI revealed that plasma extracts contain similar amounts of β-lipotropin- (β-LPH) and β-E-sized immunoreactive components, and that acute stress elevated both forms of β-El. Secondly, isolated tail arteries of SHR and WKY were perfused and field stimulated with two pulses at 1 Hz. β-E depressed stimulation-evoked vasconstriction with the same potency in both strains. Thus, basal and stress-induced levels of β-EI did not differ in SHR and WKY. Moreover, in the tail artery of both strains the sensitivity of presynaptic opioid receptors towards β-E was almost identical. If the β-E sensitivity of these receptors in other arteries of WKY and SHR is also similar, a major role of the circulating peptide in the development of hypertension is rather unlikely.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Anhut H, Knepel W, Nutto D, Hertting G (1981) Vasopressin stimulates release of β-lipotropin and β-endorphin in conscious rats as measured by radioimmunoassay of unextracted plasma. Naunyn-Schmiedeberg's Arch Pharmacol 316:59–63

    Google Scholar 

  • Farsang C, Ramirez-Gonzales MD, Mucci L, Kunos G (1980) Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats. J Pharmacol Exp Ther 214:203–208

    Google Scholar 

  • Farsang C, Varga K, Kapocsi J, Balas-Eltes A, Kunos G (1984) β-Endorphin contributes to the antihypertensive effect of clonidine in a subset of patients with essential hypertension. Neuropeptides 4:293–302

    Google Scholar 

  • Gaida W, Lang RE, Kraft K, Unger T, Ganten D (1985) Altered neuropeptide concentration in spontaneously hypertensive rats: cause or consequence? Clin Sci 68:35–43

    Google Scholar 

  • Galloway MP, Westfall TC (1982) The release of endogenous norepinephrine from the coccygeal artery of spontaneously hypertensive and Wistar-Kyoto rats. Circ Res 51:225–232

    Google Scholar 

  • Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F (1977) β-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197:1367–1369

    Google Scholar 

  • Holaday JW (1983) Cardiovascular effects of endogenous opiate systems. Ann Rev Pharmacol Toxicol 23:541–594

    Google Scholar 

  • Höllt V, Bergmann M (1982) Effects of acute and chronic haloperidol treatment on the concentrations of immunoreactive β-endorphin in plasma, pituitary and brain of rats. Neuroendocrinology 21:147–153

    Google Scholar 

  • Hughes J (1981) Peripheral opiate mechanisms. Trends Pharmacol Sci 2:21–24

    Google Scholar 

  • Hutchinson JS, Lim A, DiNicolantonio R, Clements JA, Funder JW (1981) Immunoreactive β-endorphin levels in plasma and pituitary tissue from genetically hypertensive and normotensive rats. Clin Exp Pharmacol Physiol 8:455–457

    Google Scholar 

  • Illes P, Bettermann R, Brod I, Bucher B (1987) β-Endorphin-sensitive opioid receptors in the rat tail artery. Naunyn-Schmiedeberg's Arch Pharmacol 335:420–427

    Google Scholar 

  • Illes P, Pfeiffer N (1985) Regulation of blood pressure by peripheral opioid mechanisms. In: Bevan JA, Godfraind T, Maxwell RA, Stoclet JC, Worcel M (eds) Vascular neuroeffector mechanisms. Elsevier, Amsterdam, pp 175–180

    Google Scholar 

  • Illes P, Pfeiffer N, von Kügelgen I, Starke K (1985) Presynaptic opioid receptor subtypes in the rabbit ear artery. J Pharmacol Exp Ther 232:526–533

    Google Scholar 

  • Illes P, Ramme D, Starke K (1986b) Presynaptic opioid δ-receptors in the rabbit mesenteric artery. J Physiol 379:217–228

    Google Scholar 

  • Knepel W, Nutto D, Anhut H (1983) β-Endorphin controls vasopressin release during foot shock-induced stress in the rat. Regulatory Peptides 7:9–19

    Google Scholar 

  • Kunos G, Farsang C, Ramirez-Gonzales MD (1981) β-Endorphin: possible involvement in the antihypertensive effect of central α-receptor activation. Science 211:82–84

    Google Scholar 

  • McQueen DS (1983) Opioid peptide interactions with respiratory and circulatory systems. Br Med Bull 39:77–82

    Google Scholar 

  • Medgett IC, Hicks PE, Langer SZ (1984) Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar Kyoto rat tail arteries. J Pharmacol Exp Ther 231:159–165

    Google Scholar 

  • Pelletier G, Leclerc R, Labrie F, Cote J, Chretien M, Lis M (1977) Immunohistochemical localization of β-lipotropic hormone in the pituitary gland. Endocrinology 100:770–776

    Google Scholar 

  • Pettibone DJ, Mueller GP (1981) α-Adrenergic stimulation by clonidine increases plasma concentrations of immunoreactive β-endorphin in rats. Endocrinology 109:798–802

    Google Scholar 

  • Ramirez-Gonzalez MD, Tchakarov R, Mosqueda Garcia R, Kunos G (1983) β-Endorphin acting on the brainstem is involved in the antihypertensive action of clonidine and α-methyldopa in rats. Circ Res 53:150–157

    Google Scholar 

  • Rossier J, French ED, Rivier C, Ling N, Guillemin R, Bloom F (1977) Foot-shock induced stress increases β-endorphin levels in blood but not in brain. Nature 270:618–620

    Google Scholar 

  • Sapun-Malcohn D, Farah Jr. JM, Mueller GP (1986) Serotonin and dopamine independently regulate pituitary β-endorphine release in vivo. Neuroendocrinology 42:191–196

    Google Scholar 

  • Schmitt G, Briaud B, Mialhe C, Stutinsky F (1979) Different effects of K+ and Ca2+ on MSH and ACTH release from superfused neurointermediate lobes of the rat pituitary. Neuroendocrinology 28:297–301

    Google Scholar 

  • Shropshire AT, Wendt RL (1983) Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats. J Pharmacol Exp Ther 224:494–500

    Google Scholar 

  • Smyth DG, Massey DE, Zakarian S, Finnie MDA (1979) Endorphins are stored in biologically active and inactive forms: isolation of α-N-acetyl peptides. Nature 279:252–254

    Google Scholar 

  • Usategui R, Oliver C, Vaudry H, Lombardi R, Rozenberg I, Mourre AM (1976) Immunoreactive α-MSH and ACTH levels in rat plasma and pituitary. Endocrinology 98:189–196

    Google Scholar 

  • Vermes I, Mulder GH, Smelik PG, Tilders FJH (1980) Differential control of β-endorphin/β-lipotropin secretion from anterior and intermediate lobes of the rat pituitary gland in vitro. Life Sci 27:1761–1768

    Google Scholar 

  • von Kügelgen I, Illes P, Wolf D, Starke K (1985) Presynaptic inhibitory opioid δ- and κ-receptors in a branch of the rabbit ileocolic artery. Eur J Pharmacol 118:97–105

    Google Scholar 

  • Watkins J, Fitzgerald G, Zamboulis C, Brown MJ, Dollery CT (1980) Absence of opiate and histamine H2 receptor mediated effects of clonidine. Clin Pharmacol Ther 28:605–609

    Google Scholar 

  • Westfall TC, Meldrum MJ (1985) Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension. Ann Rev Pharmacol Toxicol 25:621–641

    Google Scholar 

  • Westfall TC, Xue CY, Carpentier S, Meldrum MJ (1985) Modulation of noradrenaline release by presynaptic adrenoceptors in experimental hypertension. In: Szabadi E, Bradshaw CM, Nahorski SR (eds) Pharmacology of adrenoceptors. Verlag Chemie, Weinheim, pp 177–186

    Google Scholar 

  • Yasunari K, Kanayama Y, Kohno M, Murakawa K, Kawarabayashi T, Takeda T, Kotsugai N, Sato K (1985) Central alpha-activation by clonidine reduces plasma levels of beta-endorphin in patients with essential hypertension. Life Sci 37:1461–1467

    Google Scholar 

  • Zsoter TT, Wolchinsky C, Lawrin M, Sirko S (1982) Norephinephrine release in arteries of spontaneously hypertensive rats. Clin Exp Hyperten A 4:431–444

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was partly supported by the Deutsche Forschungsgemeinschaft (SFB 325)

Send offprint requests to B. Bucher at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bucher, B., Bettermann, R. & Illes, P. Plasma concentration and vascular effect of β-endorphin in spontaneously hypertensive and Wistar Kyoto rats. Naunyn-Schmiedeberg's Arch Pharmacol 335, 428–432 (1987). https://doi.org/10.1007/BF00165558

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165558

Key words

Navigation